中国经济网北京12月15日讯 青岛港(601298.SH)12月12日披露关于终止现金收购日照港油品码头有 限公司100%股权及日照实华原油码头有限公司50.00%股权暨关联交易的公告。 2025年2月21日，公司召开第四届董事会第二十五次会议和第四届监事会第二十二次会议，同意公 司现金收购日照港油品码头有限公司（以下简称"油品公司"）100%股权和日照实华原油码头有限公司 （以下简称"日照实华"，与"油品公司"合称"标的公司"）50.00%股权（以下简称"本次交易"），并与山 东港口日照港集团有限公司（以下简称"日照港集团"）签署《青岛港国际股份有限公司与山东港口日照 港集团有限公司关于收购日照港油品码头有限公司、日照实华原油码头有限公司股权的协议》以及《青 岛港国际股份有限公司与山东港口日照港集团有限公司之业绩承诺补偿协议》。 由于日照实华被美国列入特别指定国民清单，可能对标的公司相关业务产生较大影响，为维护公司 及股东整体利益，经与相关方磋商，公司决定终止本次交易。2025年12月12日，公司与日照港集团签署 了有关本次交易的终止协议。 根据具备从事证券服务业务资格的中联评估出具的中联评报字[2024] ...

Group 1: Company Overview - Qingdao Port International Co., Ltd. is located at No. 7, Gangji Road, Shibei District, Qingdao, Shandong Province, established on November 15, 2013, and listed on January 21, 2019 [2] - The company's main business includes loading and unloading various goods such as containers, metal ores, coal, and crude oil, as well as logistics and port value-added services, port supporting services, and financial services [2] - The revenue composition of the main business is as follows: loading and related services 56.72%, logistics and port value-added services 36.96%, port supporting services - sales of oil, electricity, and others 3.25%, port supporting services - rental income 1.95%, and port supporting services - engineering and other labor services 1.13% [2] Group 2: Financial Performance - As of September 30, 2025, Qingdao Port achieved an operating income of 14.238 billion yuan, a year-on-year increase of 1.86%, and a net profit attributable to shareholders of 4.180 billion yuan, a year-on-year increase of 6.33% [2] - The company has cumulatively distributed dividends of 12.818 billion yuan since its A-share listing, with 5.687 billion yuan distributed in the last three years [3] Group 3: Market Activity - On December 12, Qingdao Port's stock price increased by 0.58%, with a trading volume of 189 million yuan [1] - The financing buy-in amount for Qingdao Port on the same day was 5.7678 million yuan, while the financing repayment was 10.4336 million yuan, resulting in a net financing buy-in of -4.6657 million yuan [1] - As of December 12, the total balance of margin trading for Qingdao Port was 99.5233 million yuan, with a financing balance of 99.4600 million yuan, accounting for 0.21% of the circulating market value, which is below the 50th percentile level over the past year [1] Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders of Qingdao Port was 38,300, an increase of 7.23% compared to the previous period [2] - The top ten circulating shareholders include Southern S&P China A-share Large Cap Dividend Low Volatility 50 ETF Link A (008163) as the eighth largest shareholder with 25.5069 million shares, an increase of 2.8840 million shares compared to the previous period [3]

Core Viewpoint - Shandong Port Qingdao Port has achieved significant milestones in cargo throughput and container volume, positioning itself as a leading international shipping hub in Northeast Asia, with a focus on high-quality development and technological innovation [1][2][4]. Group 1: Cargo Throughput and Container Volume - Qingdao Port's cargo throughput has exceeded 700 million tons this year, achieving this milestone 15 days ahead of the previous year [1]. - The container throughput surpassed 30 million TEUs on November 26, 2023, reinforcing its competitive position in the international shipping sector [1]. Group 2: Infrastructure and Capacity Expansion - The port has initiated 15 major projects this year, increasing terminal capacity by 16 million tons and expanding yard area by 1.46 million square meters [2]. - The completion of a second 400,000-ton ore terminal has contributed to a new development pattern, enhancing the port's hardware capabilities [2]. Group 3: Technological Advancements - Qingdao Port has established the first fully automated terminal in the country and is advancing smart port upgrades, including the promotion of its self-developed A-TOS system, which has set multiple world records for automation efficiency [2]. - The port is implementing comprehensive automation across various cargo types, significantly improving operational efficiency [2]. Group 4: Customs and Logistics Enhancements - Qingdao Customs has upgraded its services to enhance logistics efficiency, implementing automated operations that streamline customs processes and reduce handling times significantly [3]. - The optimization of the "Guan Gang Tong" smart inspection platform has reduced the number of operational steps from 11 to 3, saving over 6 hours per shipment [3]. Group 5: Green and Low-Carbon Initiatives - The port is committed to integrating green and low-carbon principles throughout its development, including the use of hydrogen-powered tugs and the establishment of a hydrogen refueling station [3]. - Qingdao Port has developed a carbon neutrality evaluation standard and is actively investing in renewable energy equipment to support its green transformation [3]. Group 6: Future Goals - Qingdao Port aims to continue expanding its shipping network, strengthening infrastructure, deepening technological innovation, and promoting green transformation to enhance its international trade capabilities [4].

Group 1: 恒瑞医药 - Company announced that its subsidiary received approval for clinical trials of HRS9531 injection, a novel dual agonist targeting GIPR and GLP-1R, aimed at treating metabolic dysfunction-related fatty liver disease (MASH) [1] - HRS9531 injection is expected to improve blood sugar levels and reduce weight by regulating glucose and lipid metabolism, suppressing appetite, and enhancing insulin sensitivity [1] - There are currently no similar drugs approved globally for the MASH indication, and the total R&D investment for HRS9531 has reached approximately 519 million yuan [1] Group 2: 青岛港 - Company announced the termination of its cash acquisition of 100% equity in Rizhao Port Oil Products Terminal Co., Ltd. and 50% equity in Rizhao Shihua Oil Terminal Co., Ltd. due to significant impacts from Rizhao Shihua being listed on the U.S. Specially Designated Nationals list [2] - The termination agreement was signed on December 12, 2025, and will not incur any breach of contract or other liabilities, nor will it adversely affect the company's operations or financial status [2] Group 3: 隆盛科技 - Company plans to invest approximately 350 million yuan to establish a humanoid intelligent robot innovation center in Wuxi, with a focus on R&D and industrialization of humanoid robots [3] - The project will involve a total investment of about 350 million yuan, with the company covering around 200 million yuan for land and construction, while its subsidiary will invest approximately 150 million yuan for the center's operation [3] Group 4: *ST沪科 - Company received a notice from the China Securities Regulatory Commission regarding an investigation into suspected violations of information disclosure laws [4] - The company stated that its production and operations are normal and that the investigation will not have a significant impact on its management [4] Group 5: 永鼎股份 - Company clarified that it does not directly manufacture controllable nuclear fusion devices, despite being listed as a related concept stock [5] - The revenue from its subsidiary related to this area accounts for less than 1% of the company's total revenue and is currently operating at a loss [5] - The controlling shareholder reduced its stake by 1.336 million shares during a period of abnormal stock trading [5] Group 6: 亚翔集成 - Company announced that its shareholder EVER CREATIVE reduced its stake by 414,000 shares on December 11, 2025, amid significant stock price fluctuations [6] - The stock experienced a cumulative price deviation exceeding 20% over two consecutive trading days [6] Group 7: 恩捷股份 - Company plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance and will resume trading on December 15 [8] Group 8: 芯原股份 - Company announced the termination of its plan to acquire 97% of Chipwise Technology due to discrepancies between the management's core demands and market conditions [9] - The decision was made to protect the interests of the company and its shareholders [9]

Core Viewpoint - Qingdao Port announced the termination of its acquisition of 100% equity in Rizhao Port Oil Products Company and 50% equity in Rizhao Shihua Oil Terminal due to potential business impacts from Rizhao Shihua being listed on the U.S. Specially Designated Nationals List [1] Group 1 - On December 12, 2025, Qingdao Port held meetings to approve the cash acquisition of the target companies [1] - The acquisition agreement was signed with Shandong Port Rizhao Port Group [1] - The decision to terminate the transaction was made after discussions with relevant parties to protect the interests of the company and its shareholders [1] Group 2 - A termination agreement regarding the acquisition was signed with Rizhao Port Group on December 12, 2025 [1]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

智通财经APP讯，青岛港(06198)发布公告，有关青岛港国际股份有限公司(本公司)拟以现金收购日照港 油品码头有限公司(油品公司)100%股权及日照实华原油码头有限公司(日照实华)50.00%股权(合称"标的 公司")的须予披露交易及关连交易。由于日照实华被美国列入特别指定国民清单，可能对标的公司相关 业务产生较大影响，为维护本公司及股东整体利益，经与相关方磋商，本公司决定终止本次交易。于 2025年12月12日，本公司与日照港集团签署了有关本次交易的终止协议。 终止本次交易不会产生相关违约责任或其他责任。终止本次交易不会损害本公司及股东利益，不会对本 公司生产经营活动和财务状况造成不利影响。 （原标题：青岛港(06198)终止收购油品公司及日照实华股权） ...

终止本次交易不会产生相关违约责任或其他责任。终止本次交易不会损害本公司及股东利益，不会对本 公司生产经营活动和财务状况造成不利影响。 青岛港（601298）(06198)发布公告，有关青岛港国际股份有限公司(本公司)拟以现金收购日照港 （600017）油品码头有限公司(油品公司)100%股权及日照实华原油码头有限公司(日照实华)50.00%股权 (合称"标的公司")的须予披露交易及关连交易。由于日照实华被美国列入特别指定国民清单，可能对标 的公司相关业务产生较大影响，为维护本公司及股东整体利益，经与相关方磋商，本公司决定终止本次 交易。于2025年12月12日，本公司与日照港集团签署了有关本次交易的终止协议。 ...

格隆汇12月12日丨青岛港(06198.HK)发布公告，有关公司拟以现金收购日照港油品码头有限公司("油品 公司")100%股权及日照实华原油码头有限公司("日照实华")50.00%股权(合称"标的公司")。由于日照实 华被美国列入特别指定国民清单，可能对标的公司相关业务产生较大影响，为维护公司及股东整体利 益，经与相关方磋商，公司决定终止本次交易。2025年12月12日，公司与日照港集团签署了有关本次交 易的终止协议。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依賴該等內 容而引致的任何損失承擔任何責任。 蘇建光 Qingdao Port International Co., Ltd. 青島港國際股份有限公司 （於中華人民共和國成立的股份有限公司） （股份代號：06198） 關於終止收購油品公司及日照實華股權的公告 茲提述本公司日期為2025年2月21日及2025年3月28日的公告及日期為2025年3月7日的 通函（「通函」），內容有關青島港國際股份有限公司（「本公司」）擬以現金收購 日照港油品碼頭有限公司（「油品公司」）100%股權及日照實華原油碼頭有限公司 （「日照實華」）50.00%股權（合稱「標的公司」）的須予披露交易及關連交易 （「本次交易」）。除文義另有界定者外，本公告所用詞匯與通函所界定者具有相同 涵義。本公司於2025年3月28日召開2025年第一次臨時股東大會審議通過了本次交易。 由於日照實華被美國列入特別指定國民清單，可能對標的公司相關業務產生較大影響， 為維護本公司及股東整體利益，經 ...